AbbVie Demonstrates Leadership in HCV with New MAVYRET™ (glecaprevir/pibrentasvir) Data to be Presented at The Liver Meeting® 2017

Press/Media: Press / Media

PeriodOct 11 2017

Media coverage

2

Media coverage

  • TitleAbbVie Demonstrates Leadership in HCV with New MAVYRETâ„¢ (glecaprevir/pibrentasvir) Data to be Presented at The Liver Meeting® 2017
    Media name/outletTickerTech.com
    CountryUnited States
    Date10/11/17
    PersonsFred Poordad
  • TitleABBVIE : Demonstrates Leadership in HCV with New MAVYRET™ (glecaprevir/pibrentasvir) Data to be Presented at The Liver Meeting® 2017
    Media name/outlet4 Traders
    CountryUnited States
    Date10/11/17
    PersonsFred Poordad